Results 171 to 180 of about 100,703 (254)

Biomarkers of pulmonary fibrosis in bronchoalveolar lavage fluid and saliva. Study methods and pathophysiological significance. [PDF]

open access: yesFront Med (Lausanne)
Ángel-Reimúndez C   +6 more
europepmc   +1 more source

Bioassays in Allergy: Technical Characteristics, Limitations, and Pathways to Clinical Implementation—An EAACI Position Paper

open access: yesClinical and Translational Allergy, Volume 16, Issue 10, October 2026.
ABSTRACT Bioassays offer functional readouts of immune responses through specific biomarkers, providing mechanistic insight beyond conventional serology. By capturing cellular activation, tissue‐level changes, and molecular signaling, they hold promise for refining allergy diagnosis, risk stratification, and treatment monitoring, contributing to ...
Cagatay Karaaslan   +13 more
wiley   +1 more source

Primary pulmonary salivary gland‐type tumors in cytopathology practice: A systematic review and meta‐analysis

open access: yesCancer Cytopathology, Volume 134, Issue 10, October 2026.
Abstract Background Primary pulmonary salivary gland‐type tumors (PSGTs) are rare but clinically significant tumors that originate from the submucosal glands of the tracheobronchial tree. Cytologic samples taken during bronchoscopy are a key component of preoperative evaluation. However, cytologic diagnosis remains challenging because of the submucosal
Henri Lagerstam   +2 more
wiley   +1 more source

Sinensetin From Citrus Peel Alleviates LPS‐Induced Acute Pneumonia by Regulating HIF‐1α Signaling Pathway in Mice

open access: yeseFood, Volume 7, Issue 5, October 2026.
In this study, we found that sinensetin can effectively inhibit the inflammatory response and damage of lung cells caused by LPS in vivo and in vitro. This might be caused by the action of sinensetin in regulating the HIF‐1α‐MAPK signaling cascade.
Zuomin Hu   +9 more
wiley   +1 more source

Parasite‐Derived IL‐33 Inhibitors Prevent Bleomycin‐Induced Lung Fibrosis

open access: yesEuropean Journal of Immunology, Volume 56, Issue 10, October 2026.
Infection with the intestinal helminth Heligmosomoides polygyrus bakeri, or administration of the parasite products (HES), or administration of recombinant HpARI2+HpBARI_Hom2 can all suppress the development of lung fibrosis in the mouse bleomycin model, via suppression of the IL‐33 pathway. Graphic abstract created in BioRender. McSorley, HJ.
Samuele Di Carmine   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy